EchoNext

Trends

• FDA authorizations extend clinical AI into new specialties and LLMs

Items

1. Jun 23

   FDA clears Pathway Labs' EchoNext

   The first FDA-cleared multicondition cardiac AI reads standard 12-lead ECGs to flag six structural heart diseases, trained on 700,000+ ECG-echocardiogram pairs, and is distributed through OpenEvidence, the clinical-decision platform used by more than half of US clinicians.